Genetic alterations of driver genes as independent prognostic factors for disease-free survival in patients with resected non-small cell lung cancer

This publication has 19 references indexed in Scilit:

• Prognostic Impact of Tumor Mutation Burden in Patients With Completely Resected Non–Small Cell Lung Cancer: Brief Report
  Journal of Thoracic Oncology, 2018
• Risk factors for local recurrence after lobectomy and lymph node dissection in patients with non-small cell lung cancer: Implications for adjuvant therapy
  Lung Cancer, 2018
• A randomized Phase III trial of lobe-specific vs. systematic nodal dissection for clinical Stage I–II non-small cell lung cancer (JCOG1413)
  Japanese Journal of Clinical Oncology, 2017
• Next generation sequencing approach for detecting 491 fusion genes from human cancer
  Biomedical Research, 2016
• Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA
  PLOS ONE, 2015
• Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
  JAMA, 2014
• PurBayes: estimating tumor cellularity and subclonality in next-generation sequencing data
  Bioinformatics, 2013
• Recurrence of mediastinal node cancer after lobe-specific systematic nodal dissection for non-small-cell lung cancer
  European Journal of Cardio-Thoracic Surgery, 2013
• Cancer Genome Landscapes
  Science, 2013
• Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data
  The Lancet, 2010